8-((3R)-3-AMINOPIPERIDIN-1-YL)-3-METHYL-1-((4-METHYLQUINAZOLIN-2-YL)METHYL)-7-(3-OXOBUTYL)PURINE-2,6-DIONE
UNII GY3HW2EE4S
Substance Identification & Data
This profile provides standardized clinical and technical data for 8-((3r)-3-aminopiperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-7-(3-oxobutyl)purine-2,6-dione, uniquely identified by the FDA Unique Ingredient Identifier (UNII) GY3HW2EE4S.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C25H30N8O3 CKNGWQRUCZYQBG-QGZVFWFLSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 8-((3r)-3-aminopiperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-7-(3-oxobutyl)purine-2,6-dione. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.